Oppenheimer Comments on Chromadex's Q4 2019 Earnings Results $CDXC

Chromadex (ticker: CDXC) reported Q4 2019 results yesterday. The following are comments from Oppenheimer analyst Brian Nagel:

Key Quotes from Chromadex's Q4 2019 Earnings Call $CDXC

Chromadex (ticker: CDXC) reported Q4 2019 results yesterday. The following are key earnings call quotes from CEO Rob Fried, CFO Kevin Farr and Executive Chairman Frank L. Jaksche:

Key Takeaways from Chromadex / Oppenheimer Meeting CDXC

Last week, Chromadex (ticker: CDXC) CEO Rob Fried and CFO Kevin Farr met with Oppenheimer analyst Brian Nagel in NYC. The following are Nagel's key takeaways: